Phase II Trial of SAHA & Tamoxifen for Patients With Breast Cancer
Public ClinicalTrials.gov record NCT00365599. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase II Trial of Suberoylanilide Hydroxamic Acid (SAHA, Vorinostat) in Combination With Tamoxifen for Patients With Advanced Breast Cancer Who Have Failed Prior Anti-hormonal Therapy.
Study identification
- NCT ID
- NCT00365599
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Other
- Enrollment
- 43 participants
Conditions and interventions
Conditions
Interventions
- suberoylanilide hydroxamic acid (SAHA, Vorinostat) Drug
- tamoxifen citrate (Tamoxifen) Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2006
- Primary completion
- Mar 31, 2011
- Completion
- Jul 31, 2012
- Last update posted
- Nov 20, 2014
2006 – 2012
United States locations
- U.S. sites
- 8
- U.S. states
- 3
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of California | San Francisco | California | 94143 | — |
| Bethesda Memorial Hospital Research Center | Boynton Beach | Florida | 33435 | — |
| M.D. Anderson of Orlando | Orlando | Florida | 32806 | — |
| Fawcett Memorial Hospital | Port Charlotte | Florida | 33949 | — |
| Martin Memorial Cancer Center | Stuart | Florida | 34994 | — |
| Tallahassee Memorial HealthCare, Inc. | Tallahassee | Florida | 32308 | — |
| H. Lee Moffitt Cancer Center & Research Institute | Tampa | Florida | 33612 | — |
| St. Joseph's/Candler | Savannah | Georgia | 31405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00365599, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 20, 2014 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00365599 live on ClinicalTrials.gov.